Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15743201rdf:typepubmed:Citationlld:pubmed
pubmed-article:15743201lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C0007292lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C1136254lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:15743201lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:15743201pubmed:issue5lld:pubmed
pubmed-article:15743201pubmed:dateCreated2005-3-3lld:pubmed
pubmed-article:15743201pubmed:abstractTextFatty acid biosynthesis is essential for bacterial survival. Components of this biosynthetic pathway have been identified as attractive targets for the development of new antibacterial agents. FabH, beta-ketoacyl-ACP synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram-positive and -negative bacteria. Small molecules that inhibit FabH enzymatic activity have the potential to be candidates within a novel class of selective, nontoxic, broad-spectrum antibacterials. Using crystallographic structural information on these highly conserved active sites and structure based drug design principles, a benzoylaminobenzoic acid series of compounds was developed as potent inhibitors of FabH. This inhibitor class demonstrates strong antibacterial activity against Gram-positive and selected Gram-negative organisms.lld:pubmed
pubmed-article:15743201pubmed:languageenglld:pubmed
pubmed-article:15743201pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15743201pubmed:citationSubsetIMlld:pubmed
pubmed-article:15743201pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15743201pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15743201pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15743201pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15743201pubmed:statusMEDLINElld:pubmed
pubmed-article:15743201pubmed:monthMarlld:pubmed
pubmed-article:15743201pubmed:issn0022-2623lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:SuYingYlld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:AppeltKrzyszt...lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:NieZheZlld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:GajiwalaKetan...lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:LuJiaJlld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:MargosiakStep...lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:NikulinVictor...lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:YagerKraig...lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:ChuShaosongSlld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:PerrettaCarin...lld:pubmed
pubmed-article:15743201pubmed:authorpubmed-author:CortezJosephJlld:pubmed
pubmed-article:15743201pubmed:issnTypePrintlld:pubmed
pubmed-article:15743201pubmed:day10lld:pubmed
pubmed-article:15743201pubmed:volume48lld:pubmed
pubmed-article:15743201pubmed:ownerNLMlld:pubmed
pubmed-article:15743201pubmed:authorsCompleteYlld:pubmed
pubmed-article:15743201pubmed:pagination1596-609lld:pubmed
pubmed-article:15743201pubmed:dateRevised2010-10-7lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:meshHeadingpubmed-meshheading:15743201...lld:pubmed
pubmed-article:15743201pubmed:year2005lld:pubmed
pubmed-article:15743201pubmed:articleTitleStructure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.lld:pubmed
pubmed-article:15743201pubmed:affiliationDepartments of Medicinal Chemistry, Protein Biochemistry and Structural Biology, Quorex Pharmaceuticals Inc., 1890 Rutherford Road, Suite 200, Carlsbad, CA 92008, USA. zhenie@phoenixpharmaco.comlld:pubmed
pubmed-article:15743201pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15743201lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15743201lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15743201lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15743201lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15743201lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15743201lld:pubmed